Tony Cambridge/LinkedIn
May 17, 2026, 18:50
Tony Cambridge: Exploring the Pros and Cons of POCT D-Dimer in Diagnosing DVT
Tony Cambridge, Co-Chair Near Patient Testing Working Party at British In Vitro Diagnostics Association (BIVDA), shared a post on LinkedIn:
“New article alert – POCT Innovators explores the pros and cons of POCT D-dimer in diagnosing deep vein thrombosis.
One of our collaborators likened the use of POCT D-dimer to the ‘dark arts’, see why by reading our report!”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 21:30Matthew Gouveia: How VNS-REHAB Is Transforming the Future of Stroke Rehabilitation
-
Jul 8, 2026, 21:22What Hundreds of Stroke Stories Have Taught Diana Kerr About Recovery and Resilience – Stroke Foundation
-
Jul 8, 2026, 19:50Heghine Khachatryan: Why the EHC Fully Supports the Lancet Commission on Women’s Hematological Health
-
Jul 8, 2026, 19:40Autoregulation Failure in SVD and Cognitive Impairment – International Journal of Stroke
-
Jul 8, 2026, 19:30Ahmed Mostafa: Why Antibodies Cause Organ Rejection
-
Jul 8, 2026, 19:28Erika Bocanegra: Witnessing 25 Years of Progress in Bleeding Disorders Care
-
Jul 8, 2026, 19:27Ahmadou Ouedraogo: Do You Know Your Blood Type?
-
Jul 8, 2026, 19:26Javed Anees: An Evidence-Based Clinical Guide to ESA Therapy
-
Jul 8, 2026, 19:25Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research